2018
DOI: 10.1039/c8an00285a
|View full text |Cite
|
Sign up to set email alerts
|

A robust split-luciferase-based cell fusion screening for discovering myogenesis-promoting molecules

Abstract: Myogenesis-promoting chemicals are an important source of new pharmaceuticals for the treatment of skeletal muscle atrophy that impairs quality of life. This report presents a robust and quantitative bioluminescence-based assay for screening myogenesis-promoting compounds in chemical libraries. The assay system consists of two stable C2C12 myoblast cell lines, each of which expresses either an N-terminal or a C-terminal split luciferase fragment fused to a naturally split DnaE intein as an indicator for cell f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…As the model phenomenon requiring long-term observation, we selected cell fusion during myogenesis. Myogenesis is the successive process in which stem cells differentiate to myoblast, myocyte, myotubes, and finally matured myofibers. , For the in vitro study of myogenesis, mouse myoblast C2C12 cells are often used, and their fusion into nascent myotubes and subsequent fusion into elongated myotubes are observed over several days. , Previously, we developed a BL-based assay system to evaluate the progress of myogenesis using split firefly luciferase reconstitution technology and protein trans-splicing, but live-cell imaging has never been achieved. In this work, we constructed a NanoKAZ (NKAZ) version of the myogenesis assay system and conducted cellular imaging under microscopy.…”
Section: Results and Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As the model phenomenon requiring long-term observation, we selected cell fusion during myogenesis. Myogenesis is the successive process in which stem cells differentiate to myoblast, myocyte, myotubes, and finally matured myofibers. , For the in vitro study of myogenesis, mouse myoblast C2C12 cells are often used, and their fusion into nascent myotubes and subsequent fusion into elongated myotubes are observed over several days. , Previously, we developed a BL-based assay system to evaluate the progress of myogenesis using split firefly luciferase reconstitution technology and protein trans-splicing, but live-cell imaging has never been achieved. In this work, we constructed a NanoKAZ (NKAZ) version of the myogenesis assay system and conducted cellular imaging under microscopy.…”
Section: Results and Discussionmentioning
confidence: 99%
“…We previously developed a split firefly luciferase-based assay system to quantify the progress of myocyte fusion by counting the total BL intensity from the cell samples, but the state of fusing cells was not individually observed. 47 In this work, Ad-FMZ-OH was used in a split NKAZ system for long-term continuous visualization of the cell fusion progress over a day without further addition of the substrate during the observation. The results exhibited the potential of Ad-FMZ-OH for sensitive and prolonged BL imaging with single-cell resolution and expanded the application of the NLuc/NKAZ−FMZ system.…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This reaction is at the center of a variety of biochemical assays that have been used for decades to quantify biological processes, including transcription, translation, posttranscriptional regulation, and protein-protein interaction. FFLUC's dynamic range of many orders-of-magnitude coupled with a clear readout of activity has lent itself to high throughput screens to identify inhibitory compounds [48]. In the HIV field, FFLUC activity has been routinely used in viral pseudotyping assays with TZMbl target cells to measure the potency and breadth of anti-HIV broadly neutralizing antibodies, in addition to quantifying antibodydependent cellular cytotoxicity or ADCC [49].…”
Section: Introductionmentioning
confidence: 99%